Ampio (AMPE) Will Proceed with Zertane Development Following Positive Pre-IND Meetings
Tweet Send to a Friend
Ampio Pharmaceuticals, Inc. (Nasdaq: AMPE), is proceeding with the development plan for a combination product to treat both premature ejaculation ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
